Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review

Published:2023-02-01 Issue:2 Volume:16 Page:131-140
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Baysal Mehmet¹,Bayrak Meltem²,Eşkazan Ahmet Emre³^ORCID

Affiliation:

1. Division of Hematology, Ali Osman Sönmez Oncology Hospital, Bursa, Turkey

2. Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey

3. Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2023.2174515

Reference49 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms

3. A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms

4. Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study

5. High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms;Thrombosis Research;2023-11

2. In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and atrial fibrillation: insights from the National Readmissions Database;Journal of Thrombosis and Thrombolysis;2023-10-15

3. Current therapies for classic myeloproliferative neoplasms: A focus on pathophysiology and supportive care;American Journal of Health-System Pharmacy;2023-08-09

4. Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs;Current Treatment Options in Oncology;2023-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3